Form4.ai tracks every SEC insider trade in real time. See every STLN insider filing with a free account — no card.

See every STLN insider filing

Free account

Starling Oncology, Inc. (STLN) Insider Trading

Starling Oncology, Inc. (STLN) has 3 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $79K, and 2 sales totalling $13.5M. Most recent filing: Nov. 10, 2026.

Bought vs sold

Open-market value, last 90 days

Bought: $79K (1%) Sold: $13.5M (99%)
  • Bought $79K · 1%
  • Sold $13.5M · 99%

What insiders filed

Form 4 filings by type, last 90 days

Buys: 1 (33%) Sales: 2 (67%)
  • Buys 1 · 33%
  • Sales 2 · 67%

At a glance

Insiders trading
2
Largest buy
$79K
Most recent filing
Nov 10, 2026

Latest STLN Form 4 filings

Date Insider Trade Value Price since buy
Nov 10, 2026 SEC filing Chernett Jorey 10% Owner Sold $11,188,003 —
Aug 24, 2026 SEC filing Hively Brad Director Sold $1,946,310 —
Aug 17, 2026 SEC filing Chernett Jorey 10% Owner Bought $79,104 -2.6% 30D

See every STLN insider trade

Create a free account to see all 3 STLN filings from the last 90 days. No card needed.

Create free account

Want STLN insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.